Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pertuzumab
Pertuzumab
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
Seeking Alpha
Tue, 06/19/12 - 12:10 pm
breast cancer
PDL Biopharma
Genentech
Roche
Symmetry Medical
Rigel
Medivation
MRI Interventions
BioSante
Horizon Pharma
Pertuzumab
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug
Xconomy
Fri, 06/8/12 - 11:51 am
FDA
breast cancer
Roche
Perjeta
Pertuzumab
Big promise is seen in 2 new breast cancer drugs
Yahoo/AP
Wed, 12/7/11 - 10:13 pm
breast cancer
Genentech
Pertuzumab
Afinitor
Novartis
Roche CEO Schwan spotlights Roche's top three blockbuster hopefuls
Fierce Biotech
Mon, 08/22/11 - 01:16 pm
Roche
Severin Schwan
Metmab
lung cancer
lebrikizumab
Pertuzumab
asthma
breast cancer
Roche's Cancer Drug Impresses
Yahoo/Zacks.com
Fri, 07/15/11 - 02:09 pm
Roche
GSK
Pertuzumab
breast cancer
Herceptin
ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer
Yahoo/BusinessWire
Sat, 12/11/10 - 11:48 am
Immunogen
T-DM1
Pertuzumab
breast cancer
HER2 Inhibitor
trastuzumab